Real-time enrollment status for this her2-negative breast cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:46 AM UTC
| NCT Number | NCT06774027 |
| Recruiting Status | Recruiting |
| Condition | HER2-negative Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 100 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of California, San Francisco |
| Last Updated on CT.gov | December 18, 2025 (Dec 18, 2025) |
As of July 13, 2026: Clinical trial NCT06774027 is currently recruiting participants. This clinical trial study for her2-negative breast cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by University of California, San Francisco. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06774027 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06774027 was last updated Dec 18, 2025 (December 18, 2025). HelloStudys verifies this status automatically.